International Journal of Drug Policy
Volume 21, Issue 3 , Pages 160-164 , May 2010

Preventing transitions to injecting amongst young people: What is the role of Needle and Syringe Programmes?

  • Loren Brener

      Affiliations

    • National Centre in HIV Social Research, University of New South Wales, Sydney, NSW 2052, Australia
    • Corresponding Author InformationCorresponding author at: National Centre in HIV Social Research, University of New South Wales, Level 2, Webster Building UNSW Kensington, Sydney, NSW 2052, Australia. Tel.: +61 02 9385 6530/0404 033 413 (Mob); fax: +61 02 9385 6455.
    • ,
  • Catherine Spooner

      Affiliations

    • School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    • Tel.: +61 02 9385 8658.
    • ,
  • Carla Treloar

      Affiliations

    • National Centre in HIV Social Research, University of New South Wales, Sydney, NSW 2052, Australia
    • Tel.: +61 02 9385 6959.

Received 11 December 2008 ,Revised 13 March 2009 ,Accepted 25 March 2009.

References 

  1. Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006;101(4):548–555
  2. Bailey SL, Huo DZ, Garfein RS, Ouellet LJ. The use of needle exchange by young injection drug users. Journal of Acquired Immune Deficiency Syndromes. 2003;34(1):67–70
  3. Dolan K, MacDonald M, Silins E, Topp L. Needle and syringe programs: A review of the evidence. Canberra: Australian Government Department of Health and Aging; 2005;
  4. Donoghue M, Wodak A. Health and social consequences of injecting drug use. In:  Stimson G,  Des Jarlais D,  Ball A editor. Drug injecting and HIV infection: Global dimensions and social responses. London: Taylor and Francis; 1998;p. 42–57
  5. Draus P, Carlson R. Needles in the haystacks: The social context of initiation to heroin injection in rural Ohio. Substance Use & Misuse. 2006;41:1111–1124
  6. Dunn J, Laranjeira RR. Transitions in the route of cocaine administration-characteristics, direction and associated variables. Addiction. 1999;94(6):813–824
  7. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case–control study. Drug and Alcohol Dependence. 2002;66(2):189–198
  8. Guydish J, Brown C, Edgington R, Edney H, Garcia D. What are the impacts of needle exchange on young injectors?. AIDS and Behaviour. 2000;4(2):137–146
  9. Guydish J, Bucardo J, Young M, Woods W, Grinstead O. Evaluating needle exchange: Are there negative effects?. AIDS. 1993;7:871–876
  10. Hagan H, Des Jarlais D, Friedman S, Purchase D, Alter M. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health. 1995;85:1531–1537
  11. Hagan H, McGough J, Thiede H, Hopkins S, Duchin J, Alexander E. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment. 2000;19:247–252
  12. Hahn J, Page-Shafer K, Lum P, Ochoa K, Moss A. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001;34(1):180–187
  13. Hawkins J, Catalano R, Miller J. Risk and protective factors for alcohol and other drug drugs problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin. 1992;112:64–105
  14. Health Outcomes International Pty Ltd, National Centre in HIV Epidemiology and Clinical Research, & Drummond, M. (2002). Return on investment in needle and syringe programs in Australia: Summary Report. Canberra: Commonwealth Department of Health and Ageing.
  15. Heintges T, Wands J. Hepatitis C virus: Epidemiology and transmission. Hepatology. 1997;26:521–526
  16. Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Preventing and curtailing injecting drug use: A review of opportunities for developing and delivering ‘route transition interventions’. Drug and Alcohol Review. 1999;18:441–451
  17. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Education Prevention & Policy. 1998;5(2):185–194
  18. Kelley MS, Murphy S, Lune H. A cultural impact of needle exchange: The role of safer-injection mentors. Contemporary Drug Problems. 2001;28(3):485
  19. Kerr T, Tyndall M, Zhang R, Lai C, Montaner J, Wood E. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. American Journal of Public Health. 2007;97(7):1228
  20. Kirketon Road Centre . One shot. DVD and educators resource kit. Sydney: The Kirketon Road Centre; 2008;
  21. Körner H, Treloar C. Needle and syringe programmes in the local media: ‘Needle anger’ versus ‘effective education in the community’. International Journal of Drug Policy. 2004;15:46–55
  22. Kral A, Bluthenthal R, Erringer E, Lorvick J, Edlin B. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–683
  23. Lai S, Chen J, Celentano D, Page J, Lai H, Yang J, et al. Adoption of injection practices in heroin users in Guangxi Province, China. Journal of Psychoactive Drugs. 2000;32(3):285–292
  24. Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. “I inject less as I have easier access to pipes” Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy. 2008;19:255–264
  25. Loxley W. Double risk: Young injectors and sexual relationships. Sexual and Relationship Therapy. 2000;15(3):297–310
  26. Lubman I, Hides L, Yucel M, Toumbourou JW. Intervening early to reduce developmentally harmful substance use among youth populations. Medical Journal of Australia. 2007;187(7):S22–S25
  27. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Substance Use & Misuse. 2005;40(11):1681–1696
  28. McCrystal P, Higgins K, Percy A. Brief Report: School exclusion drug use and delinquency in adolescence. Journal of Adolescence. 2006;29(5):829
  29. Miller C, Johnston C, Spittal P, Li K, LaLiberte N, Montaner J, et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737–742
  30. Miller C, Strathdee S, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: Implications for intervention programs. Journal of Adolescent Health. 2006;38:462–464
  31. Murphy S, Kelly MS, Lune H. The health benefits of secondary syringe exchange. Journal of Drug Issues. 2004;34(2):245
  32. National Centre in HIV Epidemiology and Clinical Research (2008). Australian NSP Survey national data report 2003–2007. Sydney: National Centre in HIV Epidemiology and Clinical Research. The University of New South Wales.
  33. Neaigus A, Gyarmathy A, Miller M, Frajzyngier V, Friedman S, Des Jarlais D. Transitions to injecting drug use among noninjecting heroin users. Journal of Acquired Immune Deficiency Syndrome. 2006;41(4):493–503
  34. Neaigus A, Miller M, Friedman S, Hagen D, Sifaneck S, Ildefonso G, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction. 2001;96:847–860
  35. NSW Department of Health . Needle and syringe program policy and guidelines for NSW. Sydney: New South Wales Department of Health; 2006;
  36. Ompad D, et al. Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health. 2005;95(4):703–709
  37. Pearson G. The new heroin users. Oxford: Basil Blackwell; 1987;
  38. Room R. Stigma, social inequality and alcohol and drug use. Drug and Alcohol Review. 2005;24:143–155
  39. Roy, E., Boudreau, J., & Boivin, J. (in press). Hepatitis C virus incidence among young streat-involved IDUs in relation to injection experience. Drug and Alcohol Dependence.
  40. Roy E, Haley N, Leclerc P, Cedras L, Boivin J. Drug injection among street youth: The first time. Addiction. 2002;97:1003–1009
  41. Sanchez J, Chitwood D, Koo D. Risk factors associated with the transition from heroin sniffing to heroin injection: A street addict role perspective. Journal of Urban Health. 2006;83(5):896–909
  42. Spooner, C. & Hetherington, K. (2005). Social determinants of drug use. NDARC technical report 228. http://ndarc.med.unsw.edu.au/ndarcweb.nsf/website/Publications.reports.TR228. Accessed 1.05.08 (Sydney, National Drug and Alcohol Research Centre).
  43. Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment. Results from the National Treatment Outcome Research Study (NTORS). Journal of Substance Abuse Treatment. 2002;22(1):1–9
  44. Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: Differences observed in a community sample in London, UK. The American Journal of Addictions. 1999;8:148–160
  45. Treloar C, Abelson J. Information exchange among injecting drug users: A role for an expanded peer education workforce. International Journal of Drug Policy. 2005;16:46–53
  46. Treloar, C., Abelson, J., Crawford, J., Kippax, S., Howard, J., & van Beek et al. (2003). Risk for hepatitis C: Transition and initiation to injecting drug use among youth in a range of injecting drug user networks. Monograph 8/2003. Sydney: National Centre in HIV Social Research, The University of New South Wales.
  47. Treloar C, Cao W. Access to harm reduction services and ‘hidden’ injectors: Barriers to NSP use in a high drug use area of Sydney, New South Wales. International Journal of Drug Policy. 2005;16:308–315
  48. Treloar C, Fraser S. Public opinion on NSPs: Avoiding assumptions for policy and practice. Drug and Alcohol Review. 2007;26(4):355–361
  49. Treloar C, Körner H. NSPs and the media: A case study of balanced and accurate reporting?. Australian and New Zealand Journal of Public Health. 2005;29:489–490[letter]
  50. Watters J, Estilo M, Clark G, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271:115–120
  51. Weiker RL, Edgington R, Kipke MD. A collaborative evaluation of a needle exchange program for youth. Health Education & Behavior. 1999;26(2):213–224
  52. Wodak A. The world illicit drug crisis: From prohibition to reform. The International Journal of Drug Policy. 1995;5(4):218–220
  53. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use & Misuse. 2006;41:777–813
  54. Wood E, Stoltz J, Zhang R, Strathdee S, Montaner J, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high risk youth. Drug and Alcohol Review. 2008;27:270–276

PII: S0955-3959(09)00059-0

doi: 10.1016/j.drugpo.2009.03.003

International Journal of Drug Policy
Volume 21, Issue 3 , Pages 160-164 , May 2010

Article Tools